Unknown

Dataset Information

MR1 overexpression correlates with poor clinical prognosis in glioma patients.


ABSTRACT:

Background

Glioblastoma is the most common adult primary brain tumor with near-universal fatality. Major histocompatibility complex (MHC) class I molecules are important mediators of CD8 activation and can be downregulated by cancer cells to escape immune surveillance. MR1 is a nonclassical MHC-I-like molecule responsible for the activation of a subset of T cells. Although high levels of MR1 expression should enhance cancer cell recognition, various tumors demonstrate MR1 overexpression with unknown implications. Here, we study the role of MR1 in glioma.

Methods

Using multi-omics data from the Cancer Genome Atlas (TCGA), we studied MR1 expression patterns and its impact on survival for various solid tumors. In glioma specifically, we validated MR1 expression by

SUBMITTER: Kubica P 

PROVIDER: S-EPMC8080245 | biostudies-literature | 2021 Jan-Dec

REPOSITORIES: biostudies-literature